Fig 1.
Participant flow.
Table 1.
Baseline Characteristics of All Study Participants in 65 Colonies (32 in Influenza Vaccinated Group and 33 in Hepatitis A Vaccinated group) at First Entry to Study.
Table 2.
Influenza A or B Detected in All Participants in the Study a.
Table 3.
Protective Effectiveness on Nonrecipients of Immunizing Children and Adolescents With Influenza Vaccine.
Table 4.
Protective Effectiveness of Immunizing Children and Adolescents With Influenza Vaccine on All Participants.
Table 5.
Association of secondary outcomes in all participants a.